<?xml version="1.0" encoding="UTF-8"?>
<p>Abundant literature highlights sex differences in immune response and its influence on the incidence and severity of diseases. Considering trauma, shock, and infection, the female sex is associated with advantageous outcomes. Since the hormonal context exerts an important influence on the homeostasis control and the defense mechanisms, it is important to consider the beneficial effects of estrogens with regard to providing better control of defense and the different immune cells involved, in addition to cardiovascular system protection and flow maintenance. Direct and indirect mechanisms underlying the effects of estradiol were investigated, and the results point to a possible positive effect of estradiol as an adjuvant therapeutic element for the treatment of patients affected by the novel coronavirus, SARS-CoV-2 (
 <xref ref-type="fig" rid="f01">Figure 1</xref>). Studies are being carried out in order to analyze the effects estradiol on SARS-CoV-2 
 <italic>in vitro</italic>, and in parallel, there is already a clinical trial in course.
</p>
